UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2008, Methods in enzymology, ISBN 0123745845, Volume 449., xliv, 417 p. [1] p. of plate
Book
Blood, ISSN 0006-4971, 07/2015, Volume 126, Issue 5, pp. 589 - 596
Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Humans | Middle Aged | Salvage Therapy | Drug Resistance, Neoplasm | Male | Molecular Targeted Therapy | Transplantation, Homologous | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Female | Philadelphia Chromosome | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Remission Induction | Arabinonucleosides - therapeutic use | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Antibodies, Bispecific - therapeutic use | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 08/2011, Volume 118, Issue 8, pp. 2077 - 2084
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Prognosis | Prospective Studies | Gene Rearrangement, T-Lymphocyte | Humans | Risk Factors | Antineoplastic Combined Chemotherapy Protocols | Child, Preschool | Infant | Male | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Time Factors | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Adolescent | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - classification | Female | Gene Rearrangement, B-Lymphocyte | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - immunology | Child | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 02/2007, Volume 109, Issue 3, pp. 926 - 935
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Prognosis | Humans | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Classification | Adult | Female | Retrospective Studies | Cytogenetic Analysis | Child | Risk Assessment | Treatment Outcome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Algorithms | Adolescent | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - classification | Biomarkers | Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4333 - 4342
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | F-Box-WD Repeat-Containing Protein 7 | Multivariate Analysis | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Male | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Young Adult | Time Factors | DNA Mutational Analysis | Gene Deletion | Cell Cycle Proteins - genetics | Adult | Female | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | PTEN Phosphohydrolase - genetics | Genetic Predisposition to Disease | Membrane Proteins - genetics | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Phenotype | GTP Phosphohydrolases - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - classification | Mutation | Receptor, Notch1 - genetics | Ubiquitin-Protein Ligases - genetics | F-Box Proteins - genetics | Index Medicus | GTP Phosphohydrolases | ras Proteins | Innate immunity | Life Sciences | F-Box Proteins | Immunology | PTEN Phosphohydrolase | Proto-Oncogene Proteins | Membrane Proteins | Ubiquitin-Protein Ligases | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Receptor, Notch1 | Cell Cycle Proteins
Journal Article
Haematologica (Roma), ISSN 0390-6078, 05/2007, Volume 92, Issue 5, pp. 612 - 618
ALL | Allogeneic transplantation | MRD | Adult ALL | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - surgery | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Gene Deletion | Fusion Proteins, bcr-abl - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Remission Induction | Adolescent | Survival Analysis | Oncogene Proteins, Fusion - blood | Kinetics | Transplantation Conditioning | Cohort Studies | Piperazines - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Risk | Transplantation, Homologous | Neoplasm, Residual | Multicenter Studies as Topic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Polymerase Chain Reaction | Adult | Female | Myeloid-Lymphoid Leukemia Protein - blood | Gene Rearrangement, B-Lymphocyte | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | T-Cell Acute Lymphocytic Leukemia Protein 1 | Leukemia-Lymphoma, Adult T-Cell - genetics | Leukemia-Lymphoma, Adult T-Cell - surgery | Pyrimidines - administration & dosage | Gene Rearrangement, T-Lymphocyte | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Imatinib Mesylate | Biomarkers, Tumor - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzamides | Index Medicus
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 6/2011, Volume 52, Issue 6, pp. 1098 - 1107
mean fluorescence intensity (MFI) | monoclonal antibody therapy | antigen expression | antibody binding capacity (ABC) | Acute lymphoid leukemia (ALL) | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Antigens, CD - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Flow Cytometry - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Middle Aged | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Sialic Acid Binding Ig-like Lectin 2 - immunology | Antigens, CD - metabolism | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Sialic Acid Binding Ig-like Lectin 2 - metabolism | Aged, 80 and over | Adult | Transcription, Genetic | Sialic Acid Binding Ig-like Lectin 3 | Child | Antibodies, Monoclonal - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antigens, CD19 - immunology | Antigens, CD20 - immunology | Immunophenotyping | Antigens, CD20 - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Reverse Transcriptase Polymerase Chain Reaction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Oncogene Proteins, Fusion - genetics | Antigens, Differentiation, Myelomonocytic - metabolism | Adolescent | Aged | Antigens, CD19 - metabolism | Index Medicus
Journal Article
Nature immunology, ISSN 1529-2908, 03/2014, Volume 15, Issue 3, pp. 294 - 304
Life Sciences & Biomedicine | Immunology | Science & Technology | Cell Proliferation | DNA-Binding Proteins - immunology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Cell Separation | Cell Survival | Precursor Cells, B-Lymphoid - metabolism | Immunoblotting | Mice, Transgenic | Precursor Cells, B-Lymphoid - immunology | Adoptive Transfer | Disease Progression | DNA-Binding Proteins - metabolism | Cell Differentiation - immunology | Animals | Flow Cytometry | Precursor Cells, B-Lymphoid - pathology | Ikaros Transcription Factor - immunology | Fluorescent Antibody Technique | Mice | Ikaros Transcription Factor - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Apoptosis | Development and progression | Transcription factors | Genetic aspects | Acute lymphocytic leukemia | Gene mutations | Identification and classification | Index Medicus
Journal Article
Cellular and molecular life sciences : CMLS, ISSN 1420-682X, 1/2016, Volume 73, Issue 1, pp. 217 - 236
Life Sciences | Biochemistry, general | Neuroprotection | Life Sciences, general | Synaptotoxicity | Knockout mouse | MMP-24 | Neurodegenerative disease | Biomedicine general | Cell Biology | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Humans | Matrix Metalloproteinases, Membrane-Associated - analysis | Male | Amyloid beta-Protein Precursor - analysis | Cognition | Alzheimer Disease - pathology | Spatial Learning | Gene Deletion | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | HEK293 Cells | Female | Hippocampus - enzymology | Alzheimer Disease - physiopathology | Mice, Inbred C57BL | Mice, Transgenic | Amyloid Precursor Protein Secretases - analysis | Hippocampus - pathology | Alzheimer Disease - enzymology | Matrix Metalloproteinases, Membrane-Associated - genetics | Hippocampus - metabolism | Amyloid Precursor Protein Secretases - metabolism | Animals | Long-Term Potentiation | Amyloid beta-Peptides - analysis | Alzheimer Disease - genetics | Matrix Metalloproteinases, Membrane-Associated - metabolism | Hippocampus - physiopathology | Analysis | Amyloid beta-protein | Genetically modified organisms | Resveratrol | Genetic engineering | Amyloidosis | Alzheimer's disease | Proteins | Nervous system | Membranes | Peptides | Alzheimers disease | Index Medicus | Neurons and Cognition | Alzheimer Disease | Matrix Metalloproteinases, Membrane-Associated | Amyloid Precursor Protein Secretases | Amyloid beta-Peptides | Amyloid beta-Protein Precursor | Hippocampus
Journal Article